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Malaria vector control interventions rely heavily on the application of insecticides against anopheline mosquitoes,
in particular the fast-acting pyrethroids that target insect voltage-gated sodium channels (VGSC). Frequent ap-
plications of pyrethroids have resulted in resistance development in the major malaria vectors including Anopheles
funestus, where resistance is primarily metabolic and driven by the overexpression of microsomal cytochrome
P450 monooxygenases (P450s). Here we examined the pattern of cross-resistance of the pyrethroid-resistant An.
funestus strain FUMOZ-R towards transfluthrin and multi-halogenated benzyl derivatives, permethrin, cyper-
methrin and deltamethrin in comparison to the susceptible reference strain FANG. Transfluthrin and two multi-
fluorinated derivatives exhibited micromolar potency - comparable to permethrin - to functionally expressed
dipteran VGSC in a cell-based cation influx assay. The activity of transfluthrin and its derivatives on VGSC was
strongly correlated with their contact efficacy against strain FUMOZ-R, although no such correlation was obtained
for the other pyrethroids due to their rapid detoxification by the resistant strain. The low resistance levels for
transfluthrin and derivatives in strain FUMOZ-R were only weakly synergized by known P450 inhibitors such as
piperonyl butoxide (PBO), triflumizole and 1-aminobenzotriazole (1-ABT). In contrast, deltamethrin toxicity in
FUMOZ-R was synergized > 100-fold by all three P450 inhibitors. The biochemical profiling of a range of
fluorescent resorufin and coumarin compounds against FANG and FUMOZ-R microsomes identified 7-benzylox-
ymethoxy-4-trifluoromethylcoumarin (BOMFC) as a highly sensitive probe substrate for P450 activity. BOMFC
was used to develop a fluorescence-based high-throughput screening assay to measure the P450 inhibitory action
of potential synergists. Azole fungicides prochloraz and triflumizole were identified as extremely potent nano-
molar inhibitors of microsomal P450s, strongly synergizing deltamethrin toxicity in An. funestus. Overall, the
present study contributed to the understanding of transfluthrin efficacy at the molecular and organismal level and
identified azole compounds with potential to synergize pyrethroid efficacy in malaria vectors.1. Introduction
The annual infection of humans with malaria remains high with an
estimated 219 million cases and 435,000 deaths worldwide in 2017
(WHO, 2018a), the majority (~80%) occurring in sub-Saharan Africa. In
Africa malaria is primarily transmitted by sibling species from the
Gambiae complex such as Anopheles gambiae and An. arabiensis, and An.
funestus (Diptera: Culicidae) from the Funestus subgroup (Sinka et al.,
2010; Wiebe et al., 2017). Anopheles funestus is one of the major malarian).
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evier B.V. This is an open access avectors in sub-Saharan-Africa (Temu et al., 2007; Sinka et al., 2010), but
its predicted geographical occurrence differs from An. gambiae (Wiebe et
al., 2017).
Vector control interventions targeting anopheline mosquitoes mainly
rely on long-lasting insecticidal nets (LLINs) or indoor residual sprays
(IRS) (Bhatt et al., 2015; Sinka et al., 2016), using longstanding chemical
classes of insecticides addressing a few modes of action (Nauen, 2007;
Hoppe et al., 2016). For over 50 years adult mosquito control has
relied on four different chemical classes of insecticides, i.e. DDT,021
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action. This contrasts with a much larger arsenal of insecticides targeting
a much wider range of modes of action that are available for the control
of agricultural pest species (Hemingway et al., 2006; Nauen, 2006;
Sparks and Nauen, 2015). It is only very recently that the neonicotinoid
clothianidin was introduced, an agricultural pesticide with a new mode
of action for vector control uses either alone or in combination with a
pyrethroid (Fuseini et al., 2019; Fongnikin et al., 2020).
The success of pyrethroids as insecticides such as deltamethrin (Pul-
man, 2011) is mainly based on their broad activity against a diverse
range of pests and their fast knock-down action (Soderlund, 2020)
resulting from the modulation of voltage-gated sodium channels (VGSC)
in the insectsʼ central nervous system (Field et al., 2017; Scott, 2019).
Pyrethroids are broadly divided into two classes designated as type-I and
type-II pyrethroids (Soderlund, 2020), based on the respective absence
and presence of an α-cyano substituent that increases VGSC potency that
determines the evoked physiological responses (Casida et al., 1983;
Laufer et al., 1984; Soderlund and Bloomquist, 1989). Pyrethroids as
insecticide sprays for vector control were introduced in the early 1970ʼs
(permethrin) and remained the cornerstone for vector control through
the introduction of pyrethroid treated bednets 20 years ago, an inter-
vention amongst others contributing to a significant decline in clinical
cases of malaria between 2000 and 2015 (Bhatt et al., 2015). However,
the spatially expanded exposure of anopheline mosquitoes to pyrethroids
in impregnated bednets (ITNs) and LLINs, resulted in an increasing se-
lection of alleles conferring resistance (Coleman et al., 2017; WHO,
2018b; Moyes et al., 2020). Therefore, the efficacy of these control
measures is increasingly compromised by the development and spread of
pyrethroid resistance alleles in anopheline mosquitoes, including An.
funestus (Hemingway et al., 2016; Coleman et al., 2017; Hemingway,
2019).
Two major mechanisms have been described to confer pyrethroid
resistance in anopheline mosquitoes (Hemingway et al., 2004; Coleman
et al., 2017); metabolic resistance, in particular detoxification mediated
by elevated levels of microsomal cytochrome P450 monooxygenases
(P450s) (Vontas et al., 2020) known to be involved in oxidative meta-
bolism of xenobiotics (Feyereisen, 1999), and target-site mutations
resulting in decreased affinity of pyrethroids to their site of binding in
VGSC due to amino acid substitutions, also called knock-down resistance
(kdr) (Davies et al., 2007; Scott, 2019; Smith et al., 2019). Other mech-
anisms such as changes in cuticular hydrocarbons - resulting in decreased
penetration of pyrethroids - are factors shown to contribute to resistance
(Balabanidou et al., 2018).
Pyrethroid resistance in An. funestus was first described in South Af-
rica (Hargreaves et al., 2000) and shown to be synergized by piperonyl
butoxide (PBO), an inhibitor of P450 enzymes (Brooke et al., 2001).
Bednets co-impregnated with PBO and pyrethroids were only recently
endorsed to mitigate the effects of P450 associated resistance (Gleave et
al., 2018; Moyes et al., 2020). Interestingly, despite high levels of pyre-
throid resistance in An. funestus VGSC mutations known to confer kdr
have not yet been described (Irving and Wondji, 2017), whilst kdr has
become essentially fixed in populations of An. gambiae (Coetzee and
Koekemoer, 2013). Upregulated levels of P450s linked to pyrethroid
resistance in An. funestus have been reported in many field studies in
Africa (Cuamba et al., 2010; Morgan et al., 2010; Irving et al., 2012;
Djouaka et al., 2016; Sangba et al., 2016; Tchigossou et al., 2018). The
genetically duplicated and highly overexpressed P450 alleles CYP6P9a
and CYP6P9b are key determinants of pyrethroid-resistance in An.
funestus (Wondji et al., 2009; Riveron et al., 2013), that have been shown
to compromise the efficacy of pyrethroid-treated bednets (Weedall et al.,
2019). Many laboratory studies were conducted with the field-collected
An. funestus colony FUMOZ, especially strain FUMOZ-R, a
laboratory-selected reference strain expressing high levels of
P450-mediated pyrethroid resistance and lacking kdr (Coetzee and
Koekemoer, 2013). It was also shown that cuticle thickening in An.
funestus (FUMOZ) could apparently affect pyrethroid penetration and2
thus contributing as an adjunct to the primary mechanism of resistance
based on P450 overexpression (Wood et al., 2010).
Not all pyrethroids are similarly affected by P450-mediated resistance
in An. funestus as recently demonstrated for the multi-halogenated benzyl
pyrethroid transfluthrin (Horstmann and Sonneck, 2016). Transfluthrin
(2,3,5,6-tetrafluorobenzyl(1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcy-
clo-propanecarboxylate; syn. benfluthrin) is an enantiomerically pure
and volatile pyrethroid exhibiting spatial repellent activity against
mosquitoes (Ogoma et al., 2012, 2014; Bibbs et al., 2018). It is under
scrutiny as a complementary outdoor-protection tool to current vector
control interventions (Kline and Urban, 2018; Masalu et al., 2020).
Here, we have examined the cross-resistance pattern of transfluthrin
and halogenated benzyl derivatives against a susceptible strain (FANG)
and the FUMOZ-R pyrethroid-resistant strain of An. funestus. We have
also measured the interactions of pyrethroids with recombinantly
expressed dipteran VGSC and explored the role of microsomal P450s in
transfluthrin metabolism and resistance by synergist studies in vivo and in
vitro. Overall, this has provided new insights on the efficacy and
resistance-breaking properties of transfluthrin in pyrethroid-resistant An.
funestus that will aid the development of new malaria control products.
2. Materials and methods
2.1. Mosquito strains
Anopheles funestus FUMOZ-R strain was obtained in 2011 from the
National Institute for Communicable Diseases - Vector Control Reference
Unit (VCRU) (Johannesburg, South Africa) and maintained at Bayer AG
(Monheim, Germany) without insecticide selection pressure. It was
originally collected in 2000 in South Mozambique and is highly resistant
to pyrethroids (Brooke et al., 2001; Hunt et al., 2005), driven by the
overexpression of cytochrome P450 monooxygenases (P450s) (Amenya
et al., 2008). The insecticide susceptible An. funestus FANG strain was
obtained in 2019 from the Liverpool Insecticide Testing Establishment
(LITE) at the Liverpool School of Tropical Medicine (LSTM). The strain
was originally received from the National Institute for Communicable
Diseases (NICD) in South Africa and collected in Angola. Both strains
were kept at 27.5 0.5 C, 65 5% relative humidity and a photoperiod
of 12/12 L:D with 1-h dusk/dawn. Adults were kept in rearing cages
(46 cm  33 cm  20 cm) and five days after hatching the first blood
meal (bovine blood, obtained from Elocin Laboratory, Oberhausen,
Germany) was provided according to standard protocols (Das et al.,
2007; Human Disease Vectors (HDV) group of the Insect Pest Control
Laboratory, 2017).
2.2. Chemicals
Transfluthrin (CAS: 118712-89-3), deltamethrin (CAS: 52918-63-5),
permethrin (CAS: 52645-53-1), 1-aminobenzotriazole (1-ABT) (CAS:
1614-12-6), triflumizole (CAS: 68694-11-1) and piperonyl butoxide
(PBO) (CAS: 51-03-6) were obtained from Sigma-Aldrich/Merck
(Darmstadt, Germany) of the highest purity available. Cypermethrin, and
the transfluthrin derivatives TF-0, TF-1, TF-3 and TF-5 (Fig. 1) were of
analytical grade and obtained internally from Bayer (Leverkusen, Ger-
many). TF-5 is also known as fenfluthrin (Behrenz and Elbert, 1985).
Transfluthrin is an enantiomerically pure compound (> 98% 1R-trans; <
1.0% 1S-trans). A similar enantiomeric purity is expected for the trans-
fluthrin derivatives, which were synthesized starting from reactions of
optically active 1R-trans-permethric acid chloride with the respective
halogenated benzyl alcohol as described elsewhere (Naumann, 1990).
β-Nicotinamide adenine dinucleotide 20-phosphate (NADPH) reduced
tetrasodium salt hydrate (CAS: 2646-71-1 anhydrous, purity  93%), 7-
ethoxycoumarin (EC; CAS: 31005-02-4, purity > 99%), 7-methoxy-4-tri-
fluoromethylcoumarin (MFC; CAS: 575-04-2, purity 99%), 7-Ethoxy-4-
trifluoromethylcoumarin (EFC; CAS: 115453-82-2, purity  98%) 7-ben-
zyloxy-4-trifluoromethylcoumarin (BFC; CAS: 220001-53-6,
Fig. 1 Chemical structures of transfluthrin and its derivatives used in this study.
M. Nolden et al. Current Research in Parasitology & Vector-Borne Diseases 1 (2021) 100041purity  99%), 7- hydroxy-coumarin (HC; CAS: 93-35-6, purity 99%) 7-
hydroxy-4-trifluoromethylcoumarin (HFC; CAS: 575-03-1, purity 98%),
7-methoxyresorufin (MR; CAS: 5725-89-3, purity 98%), 7-ethoxyresor-
ufin (ER; CAS: 5725-91-7, purity  95%), 7-benzoxyresorufin (BR; CAS:
87687-02-3), 7-n-pentoxyresorufin (PR; CAS: 87687-03-4) and resorufin
sodium salt (CAS: 34994-50-8) were purchased from Sigma-Aldrich/
Merck (Darmstadt, Germany). 7-Benzyloxymethoxy resorufin (BOMR;
CAS: 87687-02-3; Vivid™ P2951) was purchased from Invitrogen,
Thermo Fisher Scientific, Waltham, USA. 7-benzyloxymethoxy-4-trifluor-
omethylcoumarin (BOMFC; CAS: 277309-33-8; purity 95%) was syn-
thesized by Enamine (Riga, Latvia). All chemicals were of analytical
grade unless otherwise stated.
2.3. Glazed tile bioassay
To generate dose-response curves of pyrethroids, An. funestus FANG
and FUMOZ-R mosquitoes were exposed to a range of different concen-
trations in a glazed tile assay as recently described by Horstmann and
Sonneck (2016). Briefly: three to five days-old mosquitoes were anes-
thetized by placing them for 1 min at20 C and afterwards on a cooling
plate at 2 C. Ten females were placed in a Petri dish (diameter: 5 cm;
height: 1 cm, including 12 ventilation holes) covered with a paper card.
Insecticides were dissolved in acetone with a starting concentration of 2,
000 ppm (equal to 100 mg/m2) and diluted in 1:5 steps to
0.0256 ppm/0.00512 ppm (0.00128/0.000256 mg/m2). Using an
Eppendorf pipette 1,125 μl of each concentration was applied onto a
glazed tile (15 cm  15 cm, ceramic, Vitra, Germany). After the evapo-
ration of acetone and mosquito recovery from anaesthetation (1 h),
mosquitoes were exposed in two replicates (n ¼ 10) for 30 min to each
insecticide concentration and afterwards transferred back to the un-
treated paper card and kept in Petri dishes overnight. A 10% dextrose
solution was provided overnight as a food source. Mortality was scored
24 h post-exposure. Acetone alone served as a control. Control mortality
between 5 and 20%was corrected using Abbottʼs formula (Abbott, 1925),
and bioassays exceeding 20% control mortality were considered invalid.
All bioassays were replicated at least five times with two replicates
(n ¼ 10) unless otherwise stated.
2.4. Synergist bioassays
Final synergist concentrations of PBO, 1-ABT and triflumizole were
chosen based on pre-assays assessing the toxicity of each P450 inhibitor
by exposing adults of both strains for 30 min to a range of concentrations
(10,000; 7,500; 5,000; 4,000; 2,000; 1,000; 500; and 250 ppm in
acetone) in a glazed tile assay as described above. After 24 h, the3
mortality was evaluated. For the final bioassays the following concen-
trations were chosen: 2,000 ppm (100 mg/m2) of triflumizole and PBO,
and 5,000 ppm (250 mg/m2) of 1-ABT for strain FUMOZ-R; 500 ppm
(25 mg/m2) of triflumizole and PBO, and 1,000 ppm (50 mg/m2) of 1-
ABT for strain FANG. Final synergist concentrations were applied onto
glazed tiles as described above. Ten female adults were exposed for
30 min to each synergist and immediately afterwards transferred to py-
rethroid treated glazed tiles as described above. As a control group,
mosquitoes which were not exposed to the synergist and completely
untreated mosquitoes were included. Mortality figures were corrected
according to Abbott (1925), and tests exceeding 20% control mortality
were considered invalid. All synergist bioassays were replicated at least
twice.
2.5. UPLC-MS/MS analysis
As the synergists were applied via tarsal contact, ultra-performance
liquid chromatography and mass spectrometry (UPLC/MS) was used to
confirm their uptake by exemplarily analyzing exposed FUMOZ-R mos-
quito adults. PBO (2,000 ppm), triflumizole (2,000 ppm) and 1-ABT
(5,000 ppm) were dissolved in acetone and applied onto a glazed tile
as described above. After acetone evaporation (1 h) 10 female FUMOZ-R
adults were exposed for 30 min to each synergist in replicates (n ¼ 2).
After exposure, mosquitoes were placed onto a cooling plate (2 C) to
separate legs and mosquito bodies. Legs and body fractions of ten
mosquitoes were pooled (n ¼ 20) in a 1.5 ml reaction tube, washed five
times in 1,100 μl acetonitrile/water (80/20) and subsequently grinded
using a micro-pestle in 1100 μl acetonitrile/water (80/20). The samples
were centrifuged at 12,000 g for 10 min at room temperature (Centri-
fuge 5418R, Eppendorf, Hamburg, Germany) and the supernatant was
transferred into a glass vial for subsequent UPLC-MS/MS analysis with
slight modifications according to a previously published protocol (Man-
jon et al., 2018). Briefly, for the chromatography on an Agilent 1290
Infinity II, a Waters Acquity HSS T3 column (2.1 50 mm, 1.8 mm) with
0.025% formic acid in acetonitrile and 0.02% formic acid in water as the
eluent in gradient mode was employed. After positive electrospray
ionization, ion transitions were recorded on a Sciex API6500 Triple
Quad. PBO, triflumizole and 1-ABT were measured in positive ion mode
(ion transitions: PBO 356 > 177, triflumizole 346 > 278, 1-ABT
135 > 90.9). The peak integrals were calibrated externally against a
standard calibration curve. The linear range for the quantification of
PBO, triflumizole, and 1-ABT was 0.25–75 ng/ml, 0.25–100 ng/ml, and
0.5–1,000 ng/ml, respectively. Samples were diluted prior to measure-
ment if needed. Recovery rates of mosquitoes exposed to the chosen
synergist concentrations and acetone only were normally close to 100%.
2.6. Voltage-gated sodium channel measurements
The intrinsic potential of transfluthrin, its derivatives and common
pyrethroids were measured in a HEK293 cell line expressing para-type
voltage-gated sodium channels of Musca domestica (GenBank:
AAB47604.1) using a Fluorescent Imaging Plate Reader, FLIPR Tetra
(Molecular Devices, San Jose, CA, USA) fluorescence-based membrane
potential assay (Molecular Devices, #R8034). Cells were plated at a
density of 40,000 cells/well two days prior to the assay on black poly-D-
lysine coated μClear 384-well plates (Greiner Bio-One, Essen, Germany),
incubated overnight at 37 C (5% CO2) and subsequently stored 24 h at
26 C. The FLIPR voltage membrane potential sensitive (MPs) dye assay
was conducted with slight modifications according to Tay et al. (2019).
Cell medium was removed, and cells were incubated for 1 h with 20 μl
per well Tyrode buffer (Sigma T2397) containing 0.01% brilliant black
(CAS: 2519-30-4) and 0.75 mg/ml MPs dye in the dark. Common pyre-
throids and transfluthrin derivatives were pre-diluted in DMSO and
further diluted to a final assay concentration of 50–0.0032 μM (delta-
methrin: 50–0.0000256 μM; cypermethrin 10–0.00064 μM) in Tyrode
buffer containing 0.03% Pluronic™ F-68 (Thermo Fisher Scientific,
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centration was added to each well and replicated four times and imme-
diately measured every 5 s using the FLIPR high throughput cellular
screening system at an emission wavelength of 565–625 nm while
excited at 510–545 nm. Maximal response-over-baseline of each kinetic
was subjected to further analysis using GraphPad Prism 8.4 (GraphPad
Software, San Diego, USA). The assay was repeated three times on
different days.
2.7. Isolation of microsomes and cytochrome P450 activity assays
Thirty to fifty adult mosquitoes (FUMOZ-R or FANG) were homoge-
nized in an Eppendorf tube (2 ml) with a micro pestle in 500 μl
homogenization-buffer (0.1M K2HPO4, 1mMDTT, 1mMEDTA, 200mM
saccharose, pH 7.6) on ice and afterwards centrifuged at 5,000 g at 4 C
for 5 min. The supernatant was centrifuged again for 20min at 15,000 g
and 4 C. The resulting supernatant was centrifuged for 1 h at 100,000 g
and 4 C (Beckman Coulter, Germany; Optima MAX-XP Benchtop Ul-
tracentrifuge, rotor: MLA 130) and the microsomal pellet was resus-
pended in 250 μl 0.1 M buffer (0.1 M K2HPO4, 1 mMDTT, 0.1 mM EDTA,
5% glycerol, pH 7.6). The protein amount was determined according to
Bradford (1976) and adjusted to 0.2 mg protein/ml.
The activity of microsomal monooxygenases was measured using a
fluorescent probe assay with different model substrates at 20  1 C.
Depending on the substrate, the final assay concentrations of fluores-
cence probes were 100 μM (PC), 50 μM (BFC, EC, EFC, MFC), 10 μM
(BOMFC) and 4 μM (BOMR, BR, ER, MR, PR) adapted from Zimmer et al.
(2014) andManjon et al. (2018). Substrate stock solutions were prepared
in DMSO at 100 mM (PC), 50 mM (BOMFC, BFC, EC, EFC, MFC), 2 mM
(BOMR) and 1 mM (BR, ER, MR), and then diluted to the respective
concentration with 0.1 M potassium-phosphate buffer (pH 7.6).
Twenty-five μl of diluted substrate solution plus 25 μl of diluted enzymes
were incubated for 1 h with and without 250 μM NADPH in a black
384-well plate (Greiner bio-one, F-bottom, PS). The reaction was repli-
cated four times and stopped by adding 50 μl of red-ox mix (25% DMSO,
50 mM Tris–HCl buffer (pH 10), 5 mM glutathione oxidized, and 0.2 U
glutathione reductase). Fluorescence was evaluated using a microplate
reader (Tecan, Spark) at the respective excitation and emission wave-
lengths as described by Zaworra and Nauen (2019). As a positive control,
rat liver microsomes (20 mg protein/ml; Sigma-Aldrich) were tested. The
resulting reaction products, i.e. HC, HFC and resorufin were used to
generate standard curves to calculate the amount of the respective
product in pmol per mg/min (Ullrich and Weber, 1972; Manjon et al.,
2018).
2.7.1. Michaelis-Menten kinetics of BOMFC O-dearylation by mosquito
microsomes
Substrate concentration dependent microsomal monooxygenase ki-
netics was evaluated using eleven different BOMFC concentrations (stock
100 mM in DMSO) between 200 μM and 0.195 μM diluted in 0.1 M
potassium-phosphate buffer (pH 7.6) containing 0.01% zwittergent 3-10
(CAS 15163-36-7, Sigma-Aldrich) and 1 mM NADPH at 20  1 C.
Mosquito microsomal membranes were diluted in buffer (0.1 M K2HPO4,
0.1 mM EDTA, 1 mM DTT, 5% glycerol pH 7.6), (0.05% bovine serum
albumin (BSA), 0.01% zwittergent 3-10) to 0.16 mg/ml corresponding to
4 μg protein per 25 μl enzyme solution. Twenty-five μl enzyme solution
and 25 μl substrate solution were incubated for 1 h in a black 384-well
plate and the reaction stopped as described above. Each reaction was
replicated four times and the fluorescent product HFC was measured at
405 nm while excited at 510 nm. Substrate saturation kinetics were
analyzed using GraphPad Prism 8.4 (Michaelis-Menten model).
2.7.2. Microsomal P450 inhibition kinetics
For the determination of IC50-values of different azole compounds
and PBO on mosquito (FUMOZ-R) microsomal P450s the probe substrate
BOMFC was used at a single concentration around the apparent Km4
value, i.e. 5 μM (Supplementary Fig. S1), following the general protocol
recently described by Haas and Nauen (2021) with minor modifications.
The chosen assay conditions were optimized for linearity with time and
protein content of 7-hydroxy-4-(trifluoromethyl) coumarin (HC) fluo-
rescent product formation. Microsomes of strain FUMOZ-R were incu-
bated to eleven different concentrations of each inhibitor. Therefore,
inhibitors were dissolved in 1:3.3 steps in DMSO at a final concentration
of 0.5%, except for epoxiconazole (2%) and uniconazole (1%) to prevent
precipitation at the highest concentration. Stock solutions were diluted
with 0.1 M potassium-phosphate buffer (pH 7.6) containing 0.01%
zwittergent 3-10 (final concentration range between 0.000596 μM and 1,
000 μM). Microsomal preparation was diluted in buffer (0.1 M K2HPO4,
0.1 mM EDTA, 1 mM DTT, 5% glycerol, pH 7.6) containing 0.01%
zwittergent and 0.05% BSA to 0.16 mg/ml protein corresponding to 4 μg
protein/well. Inhibitors and diluted microsomal preparations were
applied to a 384-well microplate (384 wells, Greiner bio-one, F-bottom,
PS) and incubated for 10 min at 20  1 C. Subsequently, 25 μl
BOMFC/NADPH (final concentration 5 μM/125 μM) solution was added
to each well and after 60 min the reaction was stopped as described
above. Each reaction was repeated four times. Final assay evaluation was
conducted in a microplate reader (Tecan Spark; Excitation: 405 nm;
Emission: 510 nm) and reactionmix containing no inhibitor served as full
enzyme activity control (100% activity). The controls lacking NADPH
and BOMFC were subtracted from each data point. A standard curve was
generated using HC to calculate the reaction velocity in pmol HC
formed/min  mg protein1. Data were analysed and IC50-values
calculated using a four-parameter non-linear regression fitting routine in
GraphPad Prism 8.4.
2.8. RNA extraction and cDNA preparation
RNA was extracted from ten adult female mosquitoes of each strain
using TRIzol™ reaction kit following manufacturerʼs instructions. Af-
terwards RNA was purified using RNAeasy MINI Kit (Qiagen, Hilden,
Germany) following manufacturerʼs instructions, including a DNAse-
digest (RNase-free DNAse Set, 79254, Qiagen, Hilden, Germany) (mod-
ifications: Trizol incubation: 10 min, the column containing RNA sample
was eluated twice to enhance RNA yields). The RNA concentrations were
photometrically determined using 260/280 nm and 230/260 nm ratios
(NanoQuant Infinite 200, Tecan, Switzerland). All samples were adjusted
to 20 ng/μl.
Afterwards the RNA quality was checked using QIAxcel capillary
electrophoresis technology following manufacturer instructions (QIAxcel
Advanced, RNA Handbook, Qiagen, Hilden, Germany). RNA cartridge
(QIAxcel RNA QC Kit v2.0, ID: 929104) and method CL-RNA were used.
QX RNA Size Marker 200–6,000 nt (Qiagen ID: 929580) and QX RNA
alignment marker (Qiagen ID: 929510) served as size marker and
alignment marker, respectively. Once the RNA quality was confirmed,
0.3 μg of total RNA in 20 μl reaction volume was used for reverse tran-
scription using IScript cDNA synthesis Kit (Bio-Rad, Hercules, USA)
following manufacturerʼs instructions.
2.9. RT-qPCR
RT-qPCR measuring expression levels of CYP6P9a and CYP6P9b was
done according to the method recently described by Boaventura et al.
(2020) using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad,
Hercules, USA) with a total volume of 10 μl using CFX384™ Real-Time
system (Bio-Rad, Hercules, USA). Samples were run in triplicate and a
non-template control was included as the negative control. Two μl of
cDNA with 5 ng/μl and each primer with 200 nM final concentrations
were used. The PCR programwas as follows: 95 C for 30 s; 95 C for 15 s;
55.5 C for 15 s plate read; steps two and three were repeated 39 times
followed by a melting curve from 65 C to 95 C in 0.5 C steps for 5 s.
Ribosomal protein S7 (RPS 7) and Actin 5c (Act) served as reference
genes in this study. Primer efficiency for each target- and reference gene
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CYP6P9a: 109.8%; CYP6P9b: 102.8%; Actin 5c: 105.9%; and RPS 7:
104.3%. Stability of the reference genes was checked with Bio-Rad CFX
Maestro 1.0 v 4.0 software (Bio-Rad, Hercules, USA) (Vandesompele et
al., 2002) and were used for normalization. In this study three to four
biological replicates of each strain (FANG and FUMOZ-R) with three
technical replicates were measured. Primers and GenBank accession
numbers are given in the supplementary information (Supplementary
Table S1).
2.10. Statistical analysis
Probit analysis of mosquito bioassay data was performed to calculate
LC50 values and the 95% confidence intervals using SPSS version 25
(heterogeneity factor 0.5). EC50-values for voltage-gated sodium channel
binding of the different pyrethroids were calculated using GraphPad
Prism 8.4 (Nonlinear regression, four parameters, variable slope, con-
straints: bottom: 0, top: 100). Pearsonʼs correlations between mosquito
bioassay data and EC50-values were analyzed using GraphPad Prism 8.4.
A one-way ANOVA was performed to analyze data for significant dif-
ferences between data obtained for strains FANG and FUMOZ-R in the
biochemical assays. Gene expression analysis was carried out employing
Bio-Rad CFX Maestro 1.0 v. 4.0 software (Bio-Rad, Hercules, USA) fol-
lowed by subsequent unpaired t-tests in qbase (Biogazelle) to compare
for significant differences in gene expression levels.
3. Results
3.1. Efficacy of different pyrethroids in glazed tile bioassays
Full dose-response glazed tile bioassays produced a small difference
in transfluthrin contact toxicity between An. funestus strains FANG and
FUMOZ-R, resulting in a resistance ratio (RR) of 2.5 (Table 1). In
contrast, FUMOZ-R exhibited high RRs of 223 and 78 against delta-
methrin and cypermethrin, respectively. Permethrin and the trans-
fluthrin derivatives TF-0 and TF-1 were the weakest pyrethroids against
both strains, with highest LC50-values, as opposed to transfluthrin and
its multifluorinated benzyl derivatives TF-3 and TF-5 (Table 1). TF-5
(fenfluthrin) exhibited high contact activity similar to transfluthrin
against both strains with a low RR for FUMOZ-R of 1.88, indicating a
lack of cross-resistance with deltamethrin and cypermethrin. Based on
LC50-values the following efficacy ranking was obtained for the trans-
fluthrin derivatives in glazed tile bioassays with strains FANG and
FUMOZ-R: TF ¼ TF-5 > TF-3 >> TF-0 ¼ TF-1 and TF ¼ TF-5 > TF-
3 > TF-1 > TF-0, respectively. Those transfluthrin derivatives with a
para-fluorinated benzyl ring, TF-1 and TF-5, showed the lowest RRs (<
2) in strain FUMOZ-R, followed by transfluthrin (2.51), TF-0 (3.77) and
TF-3 (5.77).Table 1
Log-dose probit-mortality data (24 h) for different pyrethroids against female adults
contact exposure (30 min).
Compound An. funestus FANG (susceptible)
LC50 (mg/m2) 95% CI Slope  SE n
Transfluthrin (TF) 0.023 0.0155–0.0324 1.47 0.168 420
TF-0 1.19 0.565–1.790 2.90 0.932 140
TF-1 1.42 1.02–1.85 2.97 0.453 560
TF-3 0.0494 0.0350–0.0664 1.96 0.256 420
TF-5 0.0237 0.0132–0.0394 2.03 0.243 420
Permethrin 0.543 0.409–0.702 2.28 0.294 420
Cypermethrin 0.0968 0.0686–0.1260 2.74 0.479 420
Deltamethrin 0.0206 0.0153–0.0273 1.38 0.119 420
Note: Resistance ratio (RR) ¼ LC50 FUMOZ-R divided by LC50 FANG.
Abbreviation: 95% CI, 95% confidence interval; SE, standard error.
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3.2. Sensitivity of recombinantly expressed VGSC to pyrethroids
Pyrethroid activity to M. domestica VGSCs heterologously expressed
in HEK293 cells was measured by sensing membrane potential changes
using fluorescence imaging upon pyrethroid application (Fig. 2). The
addition of deltamethrin to HEK293-VGSC cells increased the fluores-
cence signal in a concentration-dependent manner with an EC50-value of
5.29 nM (95% CI: 4.43–6.30), suggesting high intrinsic VGSC activation
(Supplementary Table S2). Cypermethrin and permethrin were signifi-
cantly less effective and showed EC50-values of 38.9 nM (95% CI:
34.2–44.3) and 721 nM (95% CI: 591–882), respectively (Fig. 2A; Sup-
plementary Table S2). The most potent compound from the transfluthrin
series was TF-5 exhibiting an EC50-value similar to permethrin (736 nM
(95% CI: 650–834)), followed by transfluthrin, TF-3, TF-1 and TF-
0 (Fig. 2B; Supplementary Table S2). The EC50-values of transfluthrin
derivatives obtained in vitrowere strongly correlated with their observed
in vivo potential in glazed tile bioassays against adult mosquitoes of both
strain FANG (Fig. 2C) and FUMOZ-R (Fig. 2D). Such a correlation was
also observed for deltamethrin, cypermethrin and permethrin, but only
in the pyrethroid susceptible strain FANG (Fig. 2C). In contrast no such
correlation was obtained for the resistant strain FUMOZ-R (Fig. 2D).
Interestingly transfluthrin and TF-5, despite being more than 100-fold
less active on VGSC, exhibited a similar in vivo efficacy based on LC50-
values in glazed tile bioassays as deltamethrin against strain FANG
(Fig. 2C), suggesting additional factors involved in acute contact toxicity
than potency on VGSC.3.3. Synergism of pyrethroid efficacy by different P450 inhibitors
Synergists were first tested for their solo contact toxicity in glazed tile
assays to select concentrations not affecting adult survival. At the highest
1-ABT concentration tested (750mg/m2), mortality in both strains was<
10%. In contrast PBO and triflumizole were toxic against both strains, but
at high concentrations. PBO and triflumizole were more active against
the susceptible FANG strain with an LC50-value of 325 mg/m2 (95% CI:
199–707) and 136 mg/m2 (95% CI: 40.5–188) respectively. Whereas
both synergists were less toxic to the resistant strain FUMOZ-R as
demonstrated by LC50-values of > 1,000 mg/m2 and 392 mg/m2 (95%
CI: 293–508) for PBO and triflumizole respectively. Sublethal concen-
trations of all synergists applied to glazed tiles were readily taken up after
30 min contact by FUMOZ-R adults as shown by UPLC/MS analysis of
legs and body extracts, confirming their internalization (Fig. 3). All
synergists were highly effective in strain FUMOZ-R in combination with
deltamethrin (Fig. 4). This included both the azole compounds tri-
flumizole and 1-ABT not previously tested for their synergistic potential
in An. funestus. The synergistic ratios for deltamethrin in strain FUMOZ-R
were> 100-fold, whereas permethrin, transfluthrin and derivatives were
significantly lower (Fig. 4, Supplementary Table S3). There was minimalof Anopheles funestus strains FANG and FUMOZ-R in glazed tile bioassays after
An. funestus FUMOZ-R (resistant) RR
LC50 (mg/m2) 95% CI Slope  SE n
0.0576 0.0191–0.112 1.6 0.218 360 2.51
4.47 2.89–6.01 3.17 0.655 360 3.77
1.41 1.15–1.83 4.79 0.772 350 0.99
0.285 0.225–0.354 3.32 0.495 360 5.77
0.0446 0.0299–0.0592 2.08 0.316 560 1.88
4.21 2.79–5.88 1.99 0.278 360 7.76
7.54 5.24–10.40 1.86 0.204 540 77.9
4.61 2.73–7.50 1.07 0.102 540 223
Fig. 2 Concentration response curves for
common pyrethroids (A) and transfluthrin
derivatives (B) measured on functionally
expressed house fly voltage-gated sodium
channels (VGSC) using a fluorescence-based
membrane potential cation influx assay.
Data are mean values  standard deviation
(SD) (n ¼ 12). C, D Pearsonʼs correlation
analysis between in vitro VGSC EC50-values
and in vivo LC50-values obtained from glazed
tile bioassays against female adults of
Anopheles funestus strains FANG (C) and
FUMOZ-R (D). Data points circled with a
dashed line represent deltamethrin, cyper-
methrin and permethrin.
Fig. 3 Tarsal uptake of different synergists by adult
females of Anopheles funestus strain FUMOZ-R by
contact exposure for 30 min on glazed tiles. A Three
different synergists were tested in vivo: piperonyl
butoxide (PBO; 100 mg/m2), triflumizole (100 mg/
m2) and 1-aminobenzotriazole (1-ABT; 250 mg/m2).
B Amount of synergist internalized and detected in
mosquito legs and bodies analyzed by UPLC/MS.
Different letters denote a significant difference (One-
way ANOVA, Tukeyʼs post-hoc comparisons, P < 0.05).
Data are mean values  standard deviation (SD)
(n ¼ 20).
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ceptible strain FANG, whereas moderate synergism was detected for the
other pyrethroids - depending on the synergist applied (Supplementary
Table S3). The synergistic ratios obtained for the transfluthrin derivatives
tested against FUMOZ-R revealed weak or no synergism for TF-1 and TF-
5 (Fig. 4), which are fluorinated at the para position of the benzyl ring
(Fig. 1). A summary of all bioassay data including 64 calculated LC50-
values, resistance factors and synergistic ratios is provided in Supple-
mentary Table S3.
3.4. Activity and inhibition of An. funestus microsomal cytochrome P450
monooxygenases
Microsomal membranes of An. funestus strain FUMOZ-R were isolated
and tested for their capacity to metabolize a range of different coumarin6
and resorufin fluorescent probe substrates. The substrate profile obtained
for FUMOZ-R microsomes revealed a clear preference for coumarins over
resorufins. It is noteworthy that the O-debenzylation of bulkier substrates
such as BFC, BOMFC and BOMR was the preferred reaction catalyzed by
An. funestusmicrosomal P450s, followed by the O-dealkylation of smaller
substrates such as EFC and MFC (Fig. 5). Those substrates showing the
highest activity with FUMOZ-R microsomes were also tested with FANG
microsomes. As expected, probe activity was consistently lower when
compared to FUMOZ-R, consistent with higher P450 activity in the
pyrethroid-resistant strain. The most active probe substrate was BOMFC.
O-debenzylation by both FANG and FUMOZ-R microsomes followed
Michaelis-Menten kinetics with apparent Km- and Vmax-values of
5.76 μM (95% CI: 3.31–9.67) and 21.5 pmol HFC/min/mg protein (95%
CI: 18.9–24.4), and 4.41 μM (95%CI: 3.64–5.33) 114 pmol HFC/min/mg
protein (95% CI: 109–119), respectively (Supplementary Fig. S1). The
Fig. 4 Heat maps displaying the synergistic ratio obtained in
glazed tile bioassays for different pyrethroid insecticides in
Anopheles funestus strain FANG (susceptible) and FUMOZ-R
(resistant) upon contact exposure to piperonyl butoxide
(PBO) (A), 1-amino-benzotriazole (1-ABT) (B) and tri-
flumizole (C), directly prior to insecticide application. Syn-
ergistic ratios (SR) were calculated by dividing the LC50 of
the insecticide by the LC50 of the insecticide þ synergist (see
Supplementary Table S3 for details).
Fig. 5 Metabolism of different cytochrome
P450 coumarin and resorufinmodel substrates
by microsomal preparations of Anopheles
funestus, strain FUMOZ-R (A) and strain FANG
(B) in comparison to FUMOZ-R with those
substrates displayinghighest cytochromeP450
activity. Data are mean values  standard de-
viation (SD) (n¼ 4). Significant differences are
denoted by ****P  0.0001. Substrate abbrevi-






sorufin; ER, 7-ethoxyresorufin; PR, 7-n-pentox-
yresorufin; BR, 7-benzyloxyresorufin ether;
BOMR, 7-benzyloxymethoxyresorufin.
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compared to FANG was correlated with the overexpression of the well-
known P450 variants CYP6P9a and CYP6P9b, as shown by RT-qPCR
(Fig. 6).
Using the highly active probe substrate BOMFC we developed a
fluorescence-based high-throughput 384-well plate assay allowing us to
assess compounds for their potential to inhibit P450 activity in7
microsomal preparations of An. funestus strain FUMOZ-R. PBO is a potent
nanomolar P450 inhibitor that is commonly used in products to inhibit
P450-based metabolism, whereas azole fungicides are known to act
synergistic in combination with certain neonicotinoids and pyrethroids,
particularly in honey bees (Iwasa et al., 2004). The azole fungicides
prochloraz (IC50 ¼ 5.92 nM), triflumizole (IC50 ¼ 46.8 nM), uniconazole
(IC50 ¼ 107 nM) were stronger inhibitors than PBO (IC50 ¼ 260 nM),
Fig. 6 Expression level (log-scale) of CYP6P9a and CYP6P9b in Anopheles
funestus strains FUMOZ-R and FANG measured by qPCR. The expression level
was normalized to RPS7 and Act (5c) reference genes. Data are mean
values  95% CI (n ¼ 4 FUMOZ-R and n ¼ 3 for FANG).
Table 2
Inhibition of cytochrome P450 activity in microsomal preparations of Anopheles
funestus FUMOZ-R by different azole fungicides using BOMFC as a substrate. The
calculated IC50-values are based on the inhibition of total microsomal mono-
oxygenase activity. Data are mean values (n ¼ 4).












Abbreviation: 95% CI, 95% confidence interval.
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ingly, 1-ABT, a widely known P450 inhibitor, showed a rather weak
inhibitory potential (IC50 ¼ 119 μM), although its synergistic potential in
vivo in combination with pyrethroids such as deltamethrin against strain
FUMOZ-R was comparable to triflumizole and PBO (Supplementary
Table S3).
4. Discussion
Based on the lack of synergism with PBO, transfluthrin has been
previously described to be less affected than phenoxybenzyl-substituted
pyrethroids (e.g. deltamethrin) by P450-mediated metabolic resistance
in the An. funestus laboratory strain FUMOZ-R (Horstmann and Sonneck,
2016), which has elevated levels of P450 activity driven by CYP6P9a and
CYP6P9b (Hunt et al., 2005; Amenya et al., 2008; Coetzee and Koeke-
moer, 2013; Riveron et al., 2013). This study has confirmed that a very
low level of cross-resistance exists between transfluthrin (RR ¼ 2.57),
and common pyrethroids such as deltamethrin (RR ¼ 223) and cyper-
methrin (RR ¼ 77.9) in FUMOZ-R compared to the susceptible strain
FANG. The low resistance ratios also extended to other transfluthrin
derivatives with varied levels of benzyl fluorination. The surprisingly low
level of permethrin resistance in FUMOZ-R is comparable to a RR of
11.49 recently reported by Williams et al. (2019) in tarsal contact (glass8
plate) bioassays, but in comparison to the insecticide susceptible An.
gambiae strain Kisumu.
Oxidation of the 40-position on the phenoxybenzyl ring is one of the
primary targets of P450 mediated metabolism of pyrethroids (Shono et
al., 1979; Stevenson et al., 2011; Kasai et al., 2014; Zimmer et al., 2014),
while other routes of metabolism include the gem dimethyl hydroxyl-
ation and an ester- or ether-cleavage (Casida et al., 1983; Weerasinghe et
al., 2001; Stevenson et al., 2011). The most active compounds against the
resistant FUMOZ-R strain were transfluthrin and TF-5 (fenfluthrin), fol-
lowed by TF-3, where fluorination of the transfluthrin benzyl ring is
expected to offer protection against P450 attack (Horstmann and Son-
neck, 2016). However, this does not explain the low resistance ratio for
the non-fluorinated TF-0 (RR ¼ 3.77), where other factors may be
contributing to reduced P450 metabolism. The most likely explanation is
the lack of the 3-phenoxybenzyl moiety, which has been shown to be less
susceptible to P450 metabolism in other pyrethroid-resistant insects such
cotton bollworm (Tan and McCaffery, 2007) and does not correlate with
pyrethroid resistance in house flies (Khan et al., 2017). Furthermore,
P450 metabolism of transfluthrin in rats is via hydrolysis rather than
benzyl ring hydroxylation (Yoshida, 2012, 2013). The RR for permethrin
was also c.10 to 30-fold lower than for cypermethrin and deltamethrin,
respectively. Taken together, this suggests a strong preference for the
presence of a 3-phenoxybenzyl moiety and an alpha-cyano group in py-
rethroid metabolism by An. funestus FUMOZ-R, possibly driven by the
extensive use of deltamethrin-treated LLINs for malaria control in Africa
that may have applied selective pressure on P450s with an active-site
preference for deltamethrin and structurally related pyrethroids.
Pyrethroid resistance in An. funestus is strongly linked to the over-
expression of CYP6P9a and CYP6P9b that can metabolize deltamethrin
and permethrin (Riveron et al, 2013, 2014; Yunta et al., 2019). However,
depending on the geographical origin of An. funestus, other P450s such as
CYP6M7 were also shown to be highly overexpressed and involved in
pyrethroid resistance (Riveron et al., 2014). Both CYP6P9a and CYP6P9b
were highly expressed in the resistant FUMOZ-R strain relative to the
susceptible FANG strain and the lack of cross-resistance with delta-
methrin or cypermethrin suggests a limited role in transfluthrin meta-
bolism; however, we did not test the expression level of CYP6M7.
Transfluthrin has a 2,3,5,6-tetrafluorobenzyl substitution pattern that
leaves the benzyl para-position (40-position) free for P450 attack. In
comparing the synergist ratios of the P450 inhibitors PBO, 1-ABT and
triflumizole (Fig. 4) where a high ratio is indicative of P450 metabolism,
it was striking that a single fluorination of the 40-position in TF-1 was
equally effective at blocking P450 metabolism as the fully fluorinated
TF-5, as evidenced by very low synergist ratios. Whereas transfluthrin,
TF-3 and TF-0 produced higher synergist ratios indicative of greater P450
metabolism possibly depending on the halogenation pattern, thus con-
firming to some extent previous mosquito studies on the importance of
the 40-position for oxidative attack (Horstmann and Sonneck, 2016).
The acute contact toxicity of permethrin against FANG was signifi-
cantly lower compared to deltamethrin and cypermethrin. Interestingly,
transfluthrin, TF-3 and TF-5 were also up-to 25-fold more active than
permethrin in glazed tile bioassays against strain FANG, although their
intrinsic activity on recombinantly expressed house fly VGSC in vitro was
not different. Since we had no access to a mosquito VGSC, we employed a
surrogate from M. domestica, a phylogenetically related dipteran species.
Dipteran VGSC proteins show a high level of conservation (Silva and
Scott, 2020) and a comparison of important amino acid residues
described for pyrethroid binding and known to confer different levels of
target-site resistance revealed 100% identity between An. funestus
(GenBank KY499806.1) and M. domestica (GenBank X96668.1) VGSC
(O’Reilly et al., 2006; Field et al., 2017). Therefore, the agonistic potency
on house fly VGSC obtained here should be a good estimate of intrinsic
pyrethroid potency in mosquitoes as well. This assumption is supported
by earlier results showing a Kd of 4.7 nM for deltamethrin on Drosophila
wildtype VGSC functionally expressed in Xenopus oocytes (Vais et al.,
2003), a value strikingly similar to the EC50 of 5.3 nM we measured
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physiological recordings on expressed Drosophila para VGSC also
revealed weaker activity of permethrin (Warmke et al., 1997), and
another study with fenfluthrin (TF-5) on wildtype Drosophila VGSC re-
ported a similar action to that for permethrin at low micromolar con-
centrations (Usherwood et al., 2007), correlating with our finding on
house fly VGSC. The discrepancy in VGSC potency between deltamethrin
and transfluthrin (and some of its derivatives) did not correlate with their
almost identical contact toxicity in glazed tile bioassays and merits
further research.
Fluorescent substrates are frequently used to measure P450 activity
and could be applied to monitor changes in P450 activity associated with
insecticide resistance. The biochemical profiling of resorufins and cou-
marins against P450-containing microsomes from An. funestus FUMOZ-R
showed a strong preference for BOMFC, BFC and BOMR, all bulky sub-
strates substituted with a benzyloxy-group. These were rapidly O-
debenzylated to provide a robust and reliable fluorescence read-out
through conversion to umbelliferone. A similar substrate preference
has been described for CYP6BQ9 and CYP6BQ23 that are also associated
with pyrethroid resistance in Tribolium castaneum and Meligethes aeneus,
respectively (Zhu et al., 2010; Zimmer et al., 2014). Resorufin ether
substrates have been used with mixed success, being suitable as substrate
probes for An. gambiae CYP6M2, CYP6Z2 and CYP6P3, but unreactive
against pyrethroid metabolising Aedes aegypti P450s. However, BOMR to
the best of our knowledge was not included in previous studies with
malaria vectors, though alternative resorufin substrates were described
in combination with CYP6P9-variants (Ibrahim et al., 2015, 2016). In
comparison with resorufin, the coumarin based substrates produced
much stronger fluorescence signals (Fig. 5). BOMFC produced the highest
fluorescence activity suggesting that this probe substrate could be
applied to biochemically profile P450 activity in mosquito populations.
This is supported by the fact that microsomal membrane preparations of
strain FUMOZ-R were significantly more active with BOMFC than those
of strain FANG. Considering the upregulation of CYP6P9a and CYP6P9b
in strain FUMOZ-R tested here, it is likely that these P450s are contrib-
uting to BOMFC O-debenzylation and hydroxycoumarin formation,
although we cannot exclude a potential role of other P450s.
We have used BOMFC to develop a biochemical microplate (384
wells) assay to screen the inhibitory potential of a range of azole com-
pounds with An. funestusmicrosomal P450s. The assay is largely based on
a recently described mechanistic bee pollinator risk assessment approach
to assess pesticide synergism issues in honey bees (Haas and Nauen,
2021). Synergistic effects of azole fungicides in combination with pyre-
throids and neonicotinoids, respectively, have been described in honey
bees at the phenotypic level (Pilling and Jepson, 1993; Iwasa et al.,
2004), but were only recently deciphered at the molecular level (Haas
and Nauen, 2021). Here, we identified prochloraz and triflumizole as
extremely potent nanomolar inhibitors of microsomal P450s of An.
funestus, and at least for triflumizole we could confirm its synergistic
potential in combination with 3-phenoxybenzyl pyrethroids against
FUMOZ-R in vivo. Quite surprising was the rather low inhibitory potential
of the triazole 1-ABT, a well-known pan-specific P450 inhibitor (Ortiz De
Montellano, 2018). Despite its weak inhibition of FUMOZ-R microsomal
P450s in vitro it was highly active in glazed tile bioassays, e.g. in com-
bination with cypermethrin. However, future work is needed to further
investigate the basis of the contrasting results. It would also be inter-
esting to assess the efficacy of triflumizole and other azole compounds
against functionally expressed An. funestus P450s such as CYP6P9a and
CYP6P9b. McLaughlin et al. (2008) tested several drugs for their inhib-
itory action on the O-debenzylation of benzyloxy-resorufin by An. gam-
biae CYP6Z2, including clotrimazole and ketoconazole, but IC50 values
were in the micromolar range and no in vivo synergist trials were con-
ducted. Here we demonstrated that azole compounds such as triflumizole
could serve as an alternative to PBO, known for its synergistic potential
against pyrethroid-resistant mosquitoes. Our results would be a good
starting point to foster additional studies on the potential of azoles as9
synergists to overcome P450-mediated pyrethroid resistance in anophe-
line mosquitoes.
5. Conclusions
The progress in malaria reduction since the turn of millennium has
largely stagnated since 2015 with mosquito resistance to pyrethroids that
are commonly used in vector control tools such as IRS and ITNs being a
threat to the goal of eradicating malaria by 2040 (https://zeroby40.co
m/). For sustainable vector control interventions, it is therefore impor-
tant to implement resistance management strategies that are based on the
most active molecules available from chemical classes with the same
mode of action. Such molecules may not necessarily break but could
substantially delay resistance. The pyrethroids most often used in vector
control possess the common structural motif of a phenoxybenzyl alcohol
coupled with a cyclopropane ring with cross-resistance trends detectable
across pyrethroid-resistant populations of An. funestus, An. gambiae, An.
arabiensis and An. coluzzii (Moyes et al., 2021). It has been suggested that
pyrethroid cross-resistance might be mitigated by employing structurally
diverse pyrethroids such as bifenthrin (Moyes et al., 2021) and trans-
fluthrin (Horstmann and Sonneck, 2016). Here, we provide further evi-
dence that multifluorinated benzyl pyrethroids offer potential resistance
breaking properties against P450-driven pyrethroid resistance in An.
funestus that require further verification in resistant field populations.
Since pyrethroid resistance inAn. funestus field strains is largely driven by
P450-mediated detoxification, we think that the findings presented here
on transfluthrin and pyrethroid synergism are highly relevant for applied
field conditions. Furthermore, we have expanded the vector control
research toolbox by the introduction of a sensitive fluorescent probe
substrate BOMFC for the biochemical monitoring of P450-mediated
resistance, and the identification of azoles such as triflumizole as new
compounds with potential to synergize pyrethroid toxicity in An. funestus
FUMOZ-R.
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